one-hundred-fourteen evaluable patients with metastatic soft tissue or bony sarcoma with measurable disease were treated with adriamycin ( doxorubicin ) administered intravenously at a dose of 60 mg/m2 on day 1 , followed by dtic ( dacarbazine ) at a dose of 750 mg/m2 ;
C0029463
bony
C0013089
doxorubicin